Clinical trial
Safety and Efficacy of Selegiline in Outpatient Treatment for Cocaine
NCT00000336 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Selegiline in Outpatient Treatment for Cocaine
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 1995
- Completion date
- March 31, 1996
- Enrollment
- 0
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.